As global markets navigate a landscape of economic resilience and inflationary pressures, Asian equities present unique opportunities for value investors. In this context, identifying undervalued stocks becomes crucial as investors seek companies with strong fundamentals that can weather market volatility and capitalize on regional growth trends.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| Vista Group International (NZSE:VGL) |
NZ$2.28 |
NZ$4.47 |
49% |
| TRIAL Holdings (TSE:141A) |
¥2793.00 |
¥5512.40 |
49.3% |
| Rakus (TSE:3923) |
¥975.90 |
¥1914.04 |
49% |
| Precision Tsugami (China) (SEHK:1651) |
HK$52.80 |
HK$103.72 |
49.1% |
| Nanjing Vazyme Biotech (SHSE:688105) |
CN¥13.61 |
CN¥26.70 |
49% |
| Livero (TSE:9245) |
¥2050.00 |
¥4087.86 |
49.9% |
| LianChuang Electronic TechnologyLtd (SZSE:002036) |
CN¥8.37 |
CN¥16.66 |
49.8% |
| Guangdong Huayan Robotics (SEHK:1021) |
HK$18.40 |
HK$36.42 |
49.5% |
| COVER (TSE:5253) |
¥1520.00 |
¥2976.17 |
48.9% |
| Chengxin Lithium Group (SZSE:002240) |
CN¥47.70 |
CN¥94.33 |
49.4% |
Underneath we present a selection of stocks filtered out by our screen.
Busy Ming Group
Overview:Busy Ming Group Co., Ltd. operates as a food and beverage retailer in China, with a market cap of HK$77.04 billion.
Operations:The company's revenue is primarily generated from its grocery store retail segment, amounting to CN¥66.17 billion.
Estimated Discount To Fair Value:37.5%
Busy Ming Group's recent earnings report shows significant growth, with net income rising to CNY 2.33 billion from CNY 833.7 million year-on-year. The stock trades at HK$353.8, below its estimated future cash flow value of HK$565.64, suggesting it is undervalued by over 20%. Analysts forecast annual profit growth of 23.9%, outpacing the Hong Kong market's average, while revenue is expected to grow at a robust rate of 17% per year.
Zylox-Tonbridge Medical Technology
Overview:Zylox-Tonbridge Medical Technology Co., Ltd. is a medical device company that offers neuro- and peripheral-vascular interventional devices in China and internationally, with a market cap of HK$6.36 billion.
Operations:The company's revenue primarily comes from the sales of neurovascular and peripheral-vascular interventional surgical devices, amounting to CN¥1.06 billion.
Estimated Discount To Fair Value:45.5%
Zylox-Tonbridge Medical Technology's stock, priced at HK$19, is trading significantly below its estimated future cash flow value of HK$34.89, indicating undervaluation by over 20%. Analysts anticipate the company's earnings to grow annually by 25.4%, surpassing the Hong Kong market average. Recent strategic moves include a share repurchase program and dividend increase to RMB 0.22 per share, enhancing shareholder value despite a forecasted low return on equity in three years (13%).
Nippon Thompson
Overview:Nippon Thompson Co., Ltd. operates under the IKO brand, specializing in the development, manufacturing, and sale of needle roller bearings, linear motion rolling guides, precision positioning tables, and machine components across Japan and several international markets including North America and Europe; it has a market cap of ¥132.73 billion.
Operations:The company's revenue segments include Needle Roller Bearings and Linear Motion Rolling Guides, which generate ¥56.53 billion, and Machine Components, contributing ¥6.50 billion.
Estimated Discount To Fair Value:41.7%
Nippon Thompson, trading at ¥1,920, is undervalued with an estimated future cash flow value of ¥3,291.04. The company has announced a share repurchase program worth ¥1.6 billion to enhance capital efficiency and shareholder profits. Analysts forecast earnings growth of 30.9% annually over the next three years, significantly outpacing the Japanese market average despite recent volatility in share price and a projected low return on equity of 14%.
Make It Happen
-
Explore the 176 names from our Undervalued Asian Stocks Based On Cash Flows screener here.
-
Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St , where we make it simple for investors like you to stay informed and proactive.
-
Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Seeking Other Investments?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SEHK:1768 SEHK:2190 and TSE:6480.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
